Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Combescure

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
Research and Practice in Thrombosis and Haemostasis|May 23, 2022
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trialMarc Blondon, Sara Cereghetti, Jérôme Pugin, et al.
Journal of Clinical Medicine|July 21, 2019
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary SyndromesNicolas Vuilleumier, Sabrina Pagano, Christophe Combescure, et al.
The Lancet. Infectious Diseases|April 9, 2018
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyAngela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, et al.
Thrombosis and Haemostasis|November 27, 2015
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient dataJean-Luc Reny, Pierre Fontana, Willibald Hochholzer, et al.
The Lancet. Infectious Diseases|August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialAngela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
The New England Journal of Medicine|April 2, 2015
Phase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeSelidji T Agnandji, Angela Huttner, Madeleine E Zinser, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
Research and Practice in Thrombosis and Haemostasis|May 23, 2022
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trialMarc Blondon, Sara Cereghetti, Jérôme Pugin, et al.
Journal of Clinical Medicine|July 21, 2019
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary SyndromesNicolas Vuilleumier, Sabrina Pagano, Christophe Combescure, et al.
The Lancet. Infectious Diseases|April 9, 2018
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyAngela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, et al.
Thrombosis and Haemostasis|November 27, 2015
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient dataJean-Luc Reny, Pierre Fontana, Willibald Hochholzer, et al.
The Lancet. Infectious Diseases|August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialAngela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
The New England Journal of Medicine|April 2, 2015
Phase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeSelidji T Agnandji, Angela Huttner, Madeleine E Zinser, et al.
Pageof 21